MX391179B - Método de preparación e intermediario de derivado de un anillo heteroaromático de seis miembros pirrolo - Google Patents

Método de preparación e intermediario de derivado de un anillo heteroaromático de seis miembros pirrolo

Info

Publication number
MX391179B
MX391179B MX2019005319A MX2019005319A MX391179B MX 391179 B MX391179 B MX 391179B MX 2019005319 A MX2019005319 A MX 2019005319A MX 2019005319 A MX2019005319 A MX 2019005319A MX 391179 B MX391179 B MX 391179B
Authority
MX
Mexico
Prior art keywords
pyrrolo
heteroaromatic ring
membered heteroaromatic
ring derivative
preparation
Prior art date
Application number
MX2019005319A
Other languages
English (en)
Other versions
MX2019005319A (es
Inventor
Bing Liu
Lin Bian
Xiaohui Gao
Original Assignee
Jiangsu Hengrui Medicine Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Hengrui Medicine Co filed Critical Jiangsu Hengrui Medicine Co
Publication of MX2019005319A publication Critical patent/MX2019005319A/es
Publication of MX391179B publication Critical patent/MX391179B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se describe un intermediario de un derivado de anillo heteroaromático de seis miembros pirrolo como un inhibidor JAK y un método de preparación del mismo, y un método para preparar un derivado de anillo heteroaromático de seis miembros pirrolo que usa el intermediario. El método mejora el rendimiento de reacción, es simple y fácil de operar y controlar, y resulta en una producción industrial expandida.
MX2019005319A 2016-11-23 2017-11-22 Método de preparación e intermediario de derivado de un anillo heteroaromático de seis miembros pirrolo MX391179B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201611035019 2016-11-23
PCT/CN2017/112237 WO2018095320A1 (zh) 2016-11-23 2017-11-22 吡咯并六元杂芳环类衍生物的制备方法及中间体

Publications (2)

Publication Number Publication Date
MX2019005319A MX2019005319A (es) 2019-06-20
MX391179B true MX391179B (es) 2025-03-21

Family

ID=62195415

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019005319A MX391179B (es) 2016-11-23 2017-11-22 Método de preparación e intermediario de derivado de un anillo heteroaromático de seis miembros pirrolo

Country Status (11)

Country Link
US (2) US10851100B2 (es)
EP (1) EP3543241B8 (es)
JP (1) JP6937828B2 (es)
KR (1) KR20190084299A (es)
CN (1) CN108884100B (es)
AU (1) AU2017366400B2 (es)
BR (1) BR112019008812A2 (es)
CA (1) CA3040981A1 (es)
MX (1) MX391179B (es)
TW (1) TWI771342B (es)
WO (1) WO2018095320A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111205290B (zh) * 2018-11-22 2021-10-08 江苏恒瑞医药股份有限公司 一种jak激酶抑制剂的结晶形式及其制备方法
CN113698404B (zh) * 2020-05-21 2023-06-16 江苏恒瑞医药股份有限公司 一种低溶剂残留的六氢环戊并[c]吡咯-2(1H)-甲酰胺化合物及其制备方法
TW202227452A (zh) * 2020-12-04 2022-07-16 大陸商廣州費米子科技有限責任公司 氮雜並環化合物、其製備方法、抑制酪氨酸激酶的方法、藥物組成物及其用途
CN112679411B (zh) * 2020-12-31 2022-04-01 上海再启生物技术有限公司 一种手性5-(甲胺基)六氢环戊并[c]吡咯-2(1H)-Boc甲磺酸盐的制备方法
WO2023016551A1 (zh) * 2021-08-12 2023-02-16 江苏恒瑞医药股份有限公司 用于治疗或预防抗宿主病的吡咯并六元杂芳物
CN120641104A (zh) 2023-02-07 2025-09-12 瑞石生物医药有限公司 一种局部给药的药物组合物、其制备方法及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA12118A (en) * 1999-12-10 2006-05-04 Pfizer Prod Inc PyrroloÄ2,3-dÜpyrimidine compounds.
OA12292A (en) 2000-06-26 2003-11-11 Pfizer Prod Inc PyrroloÄ2,3-dÜpyrimidine compounds as immunosuppressive agents.
CN101230058A (zh) 2007-01-23 2008-07-30 上海恒瑞医药有限公司 双环氮杂烷类衍生物、其制备方法及其在医药上的用途
JP2011500806A (ja) 2007-10-25 2011-01-06 メルク・シャープ・エンド・ドーム・コーポレイション 治療用化合物
TWI466885B (zh) * 2009-07-31 2015-01-01 Japan Tobacco Inc 含氮螺環化合物及其醫藥用途
US9273028B2 (en) * 2010-10-29 2016-03-01 Biogen Ma Inc. Heterocyclic tyrosine kinase inhibitors
JP6075736B2 (ja) 2011-12-21 2017-02-08 ジエンス ヘンルイ メデイシンカンパニー リミテッドJiangsu Hengrui Medicine Co.,Ltd. ピロール−6員ヘテロアリール環誘導体、その合成法およびその医薬用途
CN104470927B (zh) * 2013-06-07 2016-05-04 江苏恒瑞医药股份有限公司 一种jak激酶抑制剂的硫酸氢盐及其制备方法
LT3077395T (lt) * 2013-12-05 2018-02-12 Pfizer Inc. Pirolo[2,3-d]pirimidinilo, pirolo[2,3-b]pirazinilo ir pirolo[2,3-d]piridinilo akrilamidai
WO2016024185A1 (en) * 2014-08-12 2016-02-18 Pfizer Inc. Pyrrolo[2,3-d]pyrimidine derivatives useful for inhibiting janus kinase
ES2962330T3 (es) * 2015-01-20 2024-03-18 Wuxi Fortune Pharmaceutical Co Ltd Inhibidor de jak

Also Published As

Publication number Publication date
MX2019005319A (es) 2019-06-20
TW201837039A (zh) 2018-10-16
CN108884100A (zh) 2018-11-23
EP3543241A1 (en) 2019-09-25
CA3040981A1 (en) 2018-05-31
EP3543241B8 (en) 2022-10-12
US10851100B2 (en) 2020-12-01
EP3543241B1 (en) 2022-09-07
TWI771342B (zh) 2022-07-21
JP2019535717A (ja) 2019-12-12
EP3543241A4 (en) 2020-06-10
KR20190084299A (ko) 2019-07-16
CN108884100B (zh) 2021-04-06
BR112019008812A2 (pt) 2019-07-16
US20190308972A1 (en) 2019-10-10
AU2017366400A1 (en) 2019-05-23
US20210024521A1 (en) 2021-01-28
AU2017366400B2 (en) 2021-08-26
JP6937828B2 (ja) 2021-09-22
WO2018095320A1 (zh) 2018-05-31

Similar Documents

Publication Publication Date Title
MY172391A (en) Processes for preparing dihydropyrimidine derivatives and intermediates thereof
BR112019008812A2 (pt) método de preparação para e intermediário de derivado de pirrolo anel heteroaromático de seis elementos
CO7141404A2 (es) Procesos para producir ciertos 2 (piridin 3 il)tiazoles
CO7141403A2 (es) Procesos para producir ciertos 2 (piridin 3 il)tiazoles
MY192466A (en) Processes for the preparation of an apoptosis-inducing agent
MY207701A (en) Methods of producing omega-hydroxylated fatty acid derivatives
MX395589B (es) Método para preparar derivado de oxaespirociclo e intermediario del mismo.
AU2017358012A8 (en) Process for expanding expandable polymeric microspheres
JOP20180011A1 (ar) مشتقات بيرولو [1، 2-b]بيريدازين
MX391715B (es) Metodo para preparar intermediario de derivado de 4-metoxipirrol.
TR201907789T4 (tr) Kalkobutrol hazirlanişina yöneli̇k yöntem
EA201891769A1 (ru) СПОСОБ ПОЛУЧЕНИЯ СОЕДИНЕНИЯ ПИРРОЛО[3,2-d]ПИРИМИДИНА И ПРОМЕЖУТОЧНЫХ СОЕДИНЕНИЙ
IN2014DN09053A (es)
EA201690696A1 (ru) Способ получения адамантанамидов
WO2015159275A3 (en) An improved process for the preparation of rifamycin derivatives
CY1119857T1 (el) Ενδιαμεσα αγομελατινης και μεθοδος παρασκευης αυτων
BR112018074477A2 (pt) método de produção de ácido 3-hidroxiadípico e micro-organismo pertencente ao gênero serratia capaz de produzir ácido 3-hidroxiadípico
WO2015120111A3 (en) Expedient synthesis of sitagliptin
CO7141402A2 (es) Procesos para producir ciertos 2 (piridin 3 il)tiazoles
MX2020006040A (es) Intermedios para derivados de piperidina opticamente activos y procedimientos de preparacion de los mismos.
MX2021002064A (es) Metodo de preparacion del compuesto pirrolo-amino-piridazinona e intermedio del mismo.
MX2015010934A (es) Metodo para producir un compuesto triciclico, y un compuesto triciclico capaz de producirse por dicho metodo de produccion.
WO2018007973A3 (en) Process and intermediates for preparing benzoxazepines
MX385406B (es) Formulación de biomasa.
MY193748A (en) Microorganisms for production of o-succinylhomoserine and method for production of o-succinylhomoserine using the same